{
    "2019-06-21": [
        [
            {
                "time": "2019-06-21",
                "original_text": "Amag’s plan to bypass female libido drug pitfalls? Social media.",
                "features": {
                    "keywords": [
                        "female libido",
                        "drug",
                        "social media"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2019-06-21",
                "original_text": "Dow Jones Today: A Typical Summer Friday",
                "features": {
                    "keywords": [
                        "Dow Jones",
                        "Summer Friday"
                    ],
                    "sentiment_score": 0.3,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "finance"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2019-06-21",
                "original_text": "Oh, By the Way, This Clinical Trial Didn't Work",
                "features": {
                    "keywords": [
                        "clinical trial",
                        "failure"
                    ],
                    "sentiment_score": -0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2019-06-21",
                "original_text": "Pfizer Receives European Commission Approval For Breast Cancer Drug TALZENNA",
                "features": {
                    "keywords": [
                        "Pfizer",
                        "TALZENNA",
                        "approval",
                        "breast cancer"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-06-21",
                "original_text": "Pharma Stock Roundup: PFE to Buy ARRY, RHHBY, MRK, AZN Drugs Get Regulatory Nod",
                "features": {
                    "keywords": [
                        "PFE",
                        "ARRY",
                        "RHHBY",
                        "MRK",
                        "AZN",
                        "regulatory nod"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-06-21",
                "original_text": "Arbutus Gets Clearance to Initiate Hepatitis Study, Stock Up",
                "features": {
                    "keywords": [
                        "Arbutus",
                        "Hepatitis",
                        "clearance",
                        "stock up"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "biotech"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-06-21",
                "original_text": "Dow 30 Stock Roundup: Boeing's $6.5B Air Force Contract, Pfizer to Buy Array BioPharma",
                "features": {
                    "keywords": [
                        "Boeing",
                        "Air Force Contract",
                        "Pfizer",
                        "Array BioPharma"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "aerospace",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-06-21",
                "original_text": "European Commission Approves TALZENNA® (talazoparib) for Patients with Inherited (Germline) BRCA-Mutated Locally Advanced or Metastatic Breast Cancer",
                "features": {
                    "keywords": [
                        "European Commission",
                        "TALZENNA",
                        "BRCA-Mutated",
                        "breast cancer"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-06-21",
                "original_text": "Health Care Sector Update for 06/21/2019: CTRV, OCUL, CGC, JNJ, PFE, ABT, MRK, AMGN",
                "features": {
                    "keywords": [
                        "Health Care Sector",
                        "CTRV",
                        "OCUL",
                        "CGC",
                        "JNJ",
                        "PFE",
                        "ABT",
                        "MRK",
                        "AMGN"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}